IGF1R and neoplasm: As the tumor grows, there is a reduction in oxygen at the center of the tumor, creating adverse conditions of hypoxia, which induces increased expression of numerous pro-angiogenic factors, such as hypoxia-inducible factor 1-alpha (HIF-1α) and insulin-like growth factor type 1 receptor (IGF-1R) [3].